Related Experiment Video
Updated: May 6, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Targeted therapy for biliary tract cancer.
1Department of Internal Medicine, Medical Oncology, Kyorin University School of Medicine, 6-20-2, Shinkawa, Mitaka, Tokyo, 181-8611, Japan. jfuruse@ks.kyorin-u.ac.jp.
Effective chemotherapy, including cisplatin plus gemcitabine, is crucial for biliary tract cancer survival. Research is exploring targeted agents and monoclonal antibodies to further improve treatment outcomes for this rare, heterogeneous cancer.
Area of Science:
- Oncology
- Gastroenterology
- Cancer Research
Background:
- Biliary tract cancer (BTC) has poor prognosis, with surgery often not an option and recurrence common even after resection.
- Current standard chemotherapy for unresectable BTC involves cisplatin plus gemcitabine, based on randomized trials showing survival benefits.
Purpose of the Study:
- To review the current landscape of chemotherapy for biliary tract cancer.
- To discuss the potential role and ongoing investigation of molecular targeted agents and monoclonal antibodies in BTC treatment.
Main Methods:
- Review of recent randomized clinical trials and investigations of targeted therapies in biliary tract cancer.
- Analysis of efficacy data for combination chemotherapy and targeted agents.
Main Results:
- Cisplatin plus gemcitabine is the established standard for unresectable BTC.
- Monoclonal antibodies (bevacizumab, cetuximab) combined with gemcitabine show promising activity.
- Targeted agents as monotherapy have shown limited efficacy.
Conclusions:
- Further research, including large international randomized trials, is essential to confirm the efficacy of novel targeted agents and optimize chemotherapy regimens for BTC.
- Addressing the heterogeneity of BTC (cholangiocarcinoma, gallbladder carcinoma) is critical for therapeutic development.
More Related Videos
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy